608
Views
37
CrossRef citations to date
0
Altmetric
Pain: Commentary

Mechanism- and experience-based strategies to optimize treatment response to the capsaicin 8% cutaneous patch in patients with localized neuropathic pain

, , , , , , , , , , , , , , , , , , , & show all
Pages 527-538 | Accepted 14 Feb 2013, Published online: 21 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Terence J. Coderre. (2018) Topical drug therapeutics for neuropathic pain. Expert Opinion on Pharmacotherapy 19:11, pages 1211-1220.
Read now

Articles from other publishers (35)

Harriet I. Kemp, Jan Vollert, Nicholas W.S. Davies, Graeme J. Moyle & Andrew S.C. Rice. (2023) A Comparison of Self-reported Pain Measures Between Sensory Phenotypes in HIV-associated Sensory Neuropathy. The Journal of Pain 24:1, pages 112-127.
Crossref
Michael S. Gold & Miroslav “Misha” Backonja. 2023. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders 671 689 .
Małgorzata Malec-Milewska, Jerzy Wordliczek & Renata Zajączkowska. (2021) Repeated capsaicin patch applications in patients with localized peripheral neuropathic pain. BÓL 22:1, pages 56-65.
Crossref
Yuhui Luo, Abbie Suttle, Qiaojuan Zhang, Peng Wang & Yong Chen. (2021) Transient Receptor Potential (TRP) Ion Channels in Orofacial Pain. Molecular Neurobiology 58:6, pages 2836-2850.
Crossref
Adiba Sultana, Rajeev K. Singla, Xuefei He, Yan Sun, Md. Shahin Alam & Bairong Shen. (2021) Topical Capsaicin for the Treatment of Neuropathic Pain. Current Drug Metabolism 22:3, pages 198-207.
Crossref
Eva Uchytilova, Diana Spicarova & Jiri Palecek. (2021) Hypersensitivity Induced by Intrathecal Bradykinin Administration Is Enhanced by N-oleoyldopamine (OLDA) and Prevented by TRPV1 Antagonist. International Journal of Molecular Sciences 22:7, pages 3712.
Crossref
Vipin Arora, James N. Campbell & Man-Kyo Chung. (2021) Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. Pharmacology & Therapeutics 220, pages 107743.
Crossref
Sheng Wang, Chao Bian, Jiale Yang, Vipin Arora, Yiwei Gao, Feng Wei & Man-Kyo Chung. (2020) Ablation of TRPV1+ Afferent Terminals by Capsaicin Mediates Long-Lasting Analgesia for Trigeminal Neuropathic Pain. eneuro 7:3, pages ENEURO.0118-20.2020.
Crossref
David Gomez-Varela, Allison M. Barry & Manuela Schmidt. (2019) Proteome-based systems biology in chronic pain. Journal of Proteomics 190, pages 1-11.
Crossref
Thomas Arendt Nielsen, Matilde Alida Eriksen, Parisa Gazerani & Hjalte Holm Andersen. (2018) Psychophysical and vasomotor evidence for interdependency of TRPA1 and TRPV1-evoked nociceptive responses in human skin: an experimental study. Pain 159:10, pages 1989-2001.
Crossref
Allison M. Barry, Julia R. Sondermann, Jan-Hendrik Sondermann, David Gomez-Varela & Manuela Schmidt. (2018) Region-Resolved Quantitative Proteome Profiling Reveals Molecular Dynamics Associated With Chronic Pain in the PNS and Spinal Cord. Frontiers in Molecular Neuroscience 11.
Crossref
Aikaterini Papagianni, Gabriela Siedler, Claudia Sommer & Nurcan Üçeyler. (2018) Capsaicin 8% patch reversibly reduces A-delta fiber evoked potential amplitudes. PAIN Reports 3:2, pages e644.
Crossref
Claudia Sommer, Christian Geber, Peter Young, Raimund Forst, Frank Birklein & Benedikt Schoser. (2018) Polyneuropathies. Deutsches Ärzteblatt international.
Crossref
Julian Prosenz, Stefan NeuwerschHerwig Kloimstein, Rudolf LikarB. Gustorff & B. Gustorff. (2017) First Lumbar Treatment of Chronic Mixed Low Back Pain with High Dose Capsaicin 8% Patch. International Journal of Pain Management 1:1, pages 12-22.
Crossref
Roberto Casale, Z. Symeonidou & M. Bartolo. (2017) Topical Treatments for Localized Neuropathic Pain. Current Pain and Headache Reports 21:3.
Crossref
N. M. Malewicz, T. Mainka & C. Maier. (2016) Schmerzreduktion nach topischem Capsaicin 8 %Pain reduction by topically applied capsaicin 8 %. Der Schmerz 30:4, pages 362-364.
Crossref
Shaherin Basith, Minghua Cui, Sunhye Hong & Sun Choi. (2016) Harnessing the Therapeutic Potential of Capsaicin and Its Analogues in Pain and Other Diseases. Molecules 21:8, pages 966.
Crossref
Bárbara Frias & Adalberto Merighi. (2016) Capsaicin, Nociception and Pain. Molecules 21:6, pages 797.
Crossref
Laurent Misery. 2016. Pruritus. Pruritus 351 354 .
T. Mainka, N.M. Malewicz, R. Baron, E.K. Enax-Krumova, R.-D. Treede & C. Maier. (2016) Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain. European Journal of Pain 20:1, pages 116-129.
Crossref
Ingo W. Husstedt & Achim Frese. (2015) Periphere und zentrale neuropathische Schmerzen. DNP - Der Neurologe und Psychiater 16:11, pages 48-56.
Crossref
E. Uchytilova, D. Spicarova & J. Palecek. (2015) Single high‐concentration capsaicin application prevents c‐Fos expression in spinothalamic and postsynaptic dorsal column neurons after surgical incision. European Journal of Pain 19:10, pages 1496-1505.
Crossref
E. Niederberger, R. Kuner & G. Geißlinger. (2015) Pharmakologische Aspekte der Schmerzforschung in DeutschlandPharmacological aspects of pain research in Germany. Der Schmerz 29:5, pages 531-538.
Crossref
Julia Marie Raber, Doris Reichelt, Ute Grüneberg-Oelker, Konstanze Philipp, Bianca Stubbe-Dräger & Ingo-W. Husstedt. (2014) Capsaicin 8 % as a cutaneous patch (Qutenza™): analgesic effect on patients with peripheral neuropathic pain. Acta Neurologica Belgica 115:3, pages 335-343.
Crossref
K. Maurer, U. Binzen, H. Mörz, R.-D. Treede & W. Greffrath. (2015) Direkte Hemmung von TRPV1 durch AcetylsalicylsäureDirect inhibition of TRPV1 by acetylsalicylic acid. Der Schmerz 29:2, pages 223-226.
Crossref
Manoel Jacobsen Teixeira, Luciana Mendes Bahia Menezes, Valquiria Silva, Ricardo Galhardoni, José Sasson, Massako Okada, Kleber Paiva Duarte, Lin T. Yeng & Daniel Ciampi de Andrade. (2015) Liposomal topical capsaicin in post-herpetic neuralgia: a safety pilot study. Arquivos de Neuro-Psiquiatria 73:3, pages 237-240.
Crossref
Johannes Wohlrab, Reinhard H.H. Neubert, Marie-Luise Heskamp & Julia Michael. (2015) Cutaneous Drug Delivery of Capsaicin after in vitro Administration of the 8% Capsaicin Dermal Patch System. Skin Pharmacology and Physiology 28:2, pages 65-74.
Crossref
Marilù Giacalone, Francesco Forfori & Francesco Giunta. 2015. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease 187 195 .
Michael S. Gold & Miroslav “Misha” Backonja. 2015. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders 674 692 .
Jana Sawynok. (2014) Topical Analgesics for Neuropathic Pain in the Elderly: Current and Future Prospects. Drugs & Aging 31:12, pages 853-862.
Crossref
Nurcan Üçeyler & Claudia Sommer. (2014) High-Dose Capsaicin for the Treatment of Neuropathic Pain: What We Know and What We Need to Know. Pain and Therapy 3:2, pages 73-84.
Crossref
Joakim M. Bischoff, Thomas K. Ringsted, Marian Petersen, Claudia Sommer, Nurcan Üçeyler & Mads U. Werner. (2014) A Capsaicin (8%) Patch in the Treatment of Severe Persistent Inguinal Postherniorrhaphy Pain: A Randomized, Double-Blind, Placebo-Controlled Trial. PLoS ONE 9:10, pages e109144.
Crossref
V. Beauvieux, M. -L. Navez, B. Manissol, C. Miallon, B. Pandraux & C. Créac’h. (2014) Registre observationnel de l’efficacité et de la tolérance de la capsaïcine 8 % (Qutenza®) dans les douleurs neuropathiques périphériques localisées pharmacorésistantesObservational register of efficiency and tolerance of capsaicin 8% (Qutenza®) in refractory peripheral localized neuropathic pain. Douleur et Analgésie 27:2, pages 110-117.
Crossref
János Szolcsányi. 2014. Capsaicin as a Therapeutic Molecule. Capsaicin as a Therapeutic Molecule 1 37 .
. (2013) Capsaicin-Pflaster bei CRPS Typ IICapsaicin plasters for complex regional pain syndrome type II. Der Schmerz 27:5, pages 517-520.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.